Liquorice liquid extract 125microlitres/5ml / Ipecacuanha liquid extract 5microlitres/5ml oral solution
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Yellow Card
Report side effects (MHRA)
Drug safety updates
MHRA alerts for Liquorice + Ipecacuanha
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing the 50 most relevant studies.
Reviews & meta-analyses: 1 · 1908–2026
Showing the 50 most relevant studies, sorted by most relevant.
V. Gowthaman, Divya Sharma, Avishek Biswas, et al.
Letters In Animal Biology, 2021
Medicinal plants have grown in popularity as a result of their numerous health benefits in animals, birds, and humans. Liquorice (Glycyrrhiza glabra) is a prominent traditional medicinal plant belonging to the Fabaceae family of legumes. The principal constituent of liquorice root is glycyrrhizin. Liquorice extract have been noted to have a significant antimicrobial (antifungal, antibacterial, antibiotic, antiviral, antiseptic, and antiprotozoal) effects. Improved feed conversion ratio, average body weight, and feed intake have been observed in quails supplemented with dietary 200 ppm of liquorice root extract and 1% probiotic in their diet. The liquorice extract has been found to have immunogenic and antioxidant properties, which could help poultry improve their growth performance, feed efficiency, carcass characteristics, and serum biochemistry, and can potentially act as a viable alternative to antibiotics in the treatment and prevention of various respiratory, digestive, and immune disorders.
Abstract licence: CC BY-NC-ND 4.0
Tomáš Lener, Martin Štícha, Karel Nesměrák
Monatshefte für Chemie - Chemical Monthly, 2024
Oxford English Dictionary, 2023
Oxford English Dictionary, 2026
New Scientist, 2024
Tsutomu HATANO, Miyuki TAKAGI, Hideyuki ITO, et al.
Chemical and Pharmaceutical Bulletin, 1997
A. E. Badr, N. Omar, F. A. Badria
International Endodontic Journal, 2010
Aura Ines Urrea Trujillo, Catalina Botero Giraldo, Esther Julia Naranjo Gòmez
Acta Agronómica, 2017
P. ipecacuanha is a medicinal plant endangered in Colombia, due to the indiscriminate exploitation suffered several decades ago for its therapeutic importance. Its great medicinal value is due to emetine production and its derivatives, approached in the roots. Given these concerns, the aim of this research was to evaluate different parameters for in vitro conservation of P. ipecacuanha due to limited plant growth, using as in vitro explants plant nodes. In fact, plant growth response to 18, 23 and 25°C with and without addition to MS basal culture medium 15 and 30 gL-1 of mannitol osmotic regulator was evaluated. Registration of plant survival data (%), plant height (cm), plant development of axillary shoots, number of leaves, callus formation and vigour of developed buds and was initially performed at 3 months and then every two months until 12 months. The explants conserved for 9 months in culture medium without mannitol osmotic regulator and temperature of 18°C, showed response after transferring and reculturing in recovery culture medium for 6-8 weeks, this process had not achieved any effect on plant growth and vigour in the recovery phase. In addition, the critical parameters in the acclimatization process were determined.
Abstract licence: CC BY-NC-SA 4.0
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.